STOCK TITAN

[Form 4] USANA Health Sciences Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

USNA – Form 4 (filed 28 Jul 2025) discloses that Chief Scientific Officer Kathryn M. Armstrong exercised 1,165 restricted stock units (RSUs) on 25 Jul 2025 (code M). Each RSU converted into one common share.

To satisfy tax-withholding obligations, the issuer automatically withheld 517 shares at $31.95 per share (code F). As a result, Armstrong’s net direct ownership increased by 648 shares, ending at 648 common shares. The derivative table shows 20,256 unvested/remaining RSUs still held after the transaction. The reported RSUs vest 25 % annually from the original 25 Jul 2024 grant date.

No open-market purchases or sales were executed; activity relates solely to equity award settlement. Impact on the float and insider ownership percentage is immaterial for investors, but the filing signals continued participation in the company’s long-term incentive plan.

USNA – Modulo 4 (presentato il 28 lug 2025) rivela che la Chief Scientific Officer Kathryn M. Armstrong ha esercitato 1.165 unità di azioni vincolate (RSU) il 25 lug 2025 (codice M). Ogni RSU è stata convertita in un'azione ordinaria.

Per adempiere agli obblighi fiscali, l'emittente ha trattenuto automaticamente 517 azioni al prezzo di 31,95 $ per azione (codice F). Di conseguenza, la proprietà diretta netta di Armstrong è aumentata di 648 azioni, raggiungendo un totale di 648 azioni ordinarie. La tabella dei derivati mostra che dopo la transazione restano 20.256 RSU non maturate/residuali. Le RSU riportate maturano al 25% annuale a partire dalla data di concessione originale del 25 lug 2024.

Non sono stati effettuati acquisti o vendite sul mercato aperto; l'attività riguarda esclusivamente la liquidazione delle azioni premio. L'impatto sul flottante e sulla percentuale di proprietà degli insider è trascurabile per gli investitori, ma la comunicazione indica una continua partecipazione al piano di incentivazione a lungo termine dell'azienda.

USNA – Formulario 4 (presentado el 28 de julio de 2025) revela que la Directora Científica Kathryn M. Armstrong ejerció 1,165 unidades restringidas de acciones (RSU) el 25 de julio de 2025 (código M). Cada RSU se convirtió en una acción común.

Para cumplir con las obligaciones fiscales, el emisor retuvo automáticamente 517 acciones a $31.95 por acción (código F). Como resultado, la propiedad directa neta de Armstrong aumentó en 648 acciones, terminando con 648 acciones comunes. La tabla de derivados muestra que tras la transacción quedan 20,256 RSU no adquiridas/restantes. Las RSU reportadas se consolidan al 25% anual desde la fecha original de concesión del 25 de julio de 2024.

No se realizaron compras o ventas en el mercado abierto; la actividad se relaciona únicamente con la liquidación de premios en acciones. El impacto en el flotante y el porcentaje de propiedad de los insiders es insignificante para los inversores, pero la presentación indica una participación continua en el plan de incentivos a largo plazo de la compañía.

USNA – Form 4 (2025년 7월 28일 제출)에 따르면 최고 과학 책임자 Kathryn M. Armstrong가 2025년 7월 25일에 1,165개의 제한 주식 단위(RSU)를 행사했습니다(코드 M). 각 RSU는 보통주 1주로 전환되었습니다.

세금 원천징수 의무를 충족하기 위해 발행사는 자동으로 517주를 주당 $31.95에 원천징수했습니다(코드 F). 그 결과 Armstrong의 순 직접 소유 주식은 648주 증가하여 총 648주가 되었습니다. 파생상품 표에는 거래 후에도 20,256개의 미확정/잔여 RSU가 남아 있는 것으로 나타납니다. 보고된 RSU는 2024년 7월 25일 최초 부여일로부터 연간 25%씩 베스팅됩니다.

공개 시장에서의 매매는 없었으며, 이번 활동은 주식 보상 정산과 관련된 것입니다. 유통 주식 수 및 내부자 소유 비율에 미치는 영향은 투자자에게 미미하지만, 이번 보고는 회사의 장기 인센티브 계획에 지속적으로 참여하고 있음을 시사합니다.

USNA – Formulaire 4 (déposé le 28 juillet 2025) révèle que la Directrice Scientifique Kathryn M. Armstrong a exercé 1 165 unités d’actions restreintes (RSU) le 25 juillet 2025 (code M). Chaque RSU a été convertie en une action ordinaire.

Pour satisfaire aux obligations fiscales, l’émetteur a automatiquement retenu 517 actions au prix de 31,95 $ par action (code F). En conséquence, la propriété directe nette d’Armstrong a augmenté de 648 actions, atteignant un total de 648 actions ordinaires. Le tableau des dérivés montre qu’après la transaction, 20 256 RSU non acquises/restantes sont toujours détenues. Les RSU déclarées acquièrent 25 % par an à partir de la date d’attribution initiale du 25 juillet 2024.

Aucun achat ou vente sur le marché ouvert n’a été effectué ; l’activité concerne uniquement le règlement des attributions d’actions. L’impact sur le flottant et le pourcentage de détention des initiés est négligeable pour les investisseurs, mais le dépôt indique une participation continue au plan d’incitation à long terme de la société.

USNA – Formular 4 (eingereicht am 28. Juli 2025) zeigt, dass die Chief Scientific Officer Kathryn M. Armstrong am 25. Juli 2025 1.165 Restricted Stock Units (RSUs) ausgeübt hat (Code M). Jede RSU wurde in eine Stammaktie umgewandelt.

Zur Erfüllung der Steuerabzugsverpflichtungen behielt der Emittent automatisch 517 Aktien zu je 31,95 $ ein (Code F). Dadurch erhöhte sich Armstrongs Nettobesitz um 648 Aktien auf insgesamt 648 Stammaktien. Die Derivatetabelle zeigt, dass nach der Transaktion noch 20.256 unverfallbare/verbleibende RSUs gehalten werden. Die gemeldeten RSUs werden seit dem ursprünglichen Gewährungsdatum 25. Juli 2024 jährlich zu 25 % vestet.

Es wurden keine Käufe oder Verkäufe am offenen Markt getätigt; die Aktivität betrifft ausschließlich die Abwicklung von Aktienvergütungen. Die Auswirkung auf den Streubesitz und den Insiderbesitz ist für Investoren unerheblich, aber die Meldung signalisiert eine fortgesetzte Teilnahme am langfristigen Anreizprogramm des Unternehmens.

Positive
  • 648 shares added to direct insider holdings, indicating continued equity alignment with shareholders.
Negative
  • None.

Insights

TL;DR – Routine RSU settlement; minor net share increase, neutral market impact.

The transaction is a standard vest-and-sell-to-cover event. Exercising 1,165 RSUs and withholding 517 shares for taxes leaves 648 new shares held directly. Given USANA’s ~19 m share float, the amount is de minimis and does not alter insider ownership trends materially. No cash sale occurred, so price discovery is unaffected. Holding 20,256 remaining RSUs indicates continued alignment with shareholder value creation, but the size is too small to infer a bullish signal. Overall impact: neutral.

TL;DR – Equity award vesting aligns exec pay with investors; governance standard.

The filing illustrates USANA’s use of RSUs that vest over four years (25 % annually). Conversion and tax withholding follow best-practice procedures under Rule 16b-3. Armstrong’s retention of 648 shares post-withholding supports alignment, while remaining 20,256 RSUs provide ongoing retention incentives. No red flags on timing or magnitude. Governance impact: neutral, routine.

USNA – Modulo 4 (presentato il 28 lug 2025) rivela che la Chief Scientific Officer Kathryn M. Armstrong ha esercitato 1.165 unità di azioni vincolate (RSU) il 25 lug 2025 (codice M). Ogni RSU è stata convertita in un'azione ordinaria.

Per adempiere agli obblighi fiscali, l'emittente ha trattenuto automaticamente 517 azioni al prezzo di 31,95 $ per azione (codice F). Di conseguenza, la proprietà diretta netta di Armstrong è aumentata di 648 azioni, raggiungendo un totale di 648 azioni ordinarie. La tabella dei derivati mostra che dopo la transazione restano 20.256 RSU non maturate/residuali. Le RSU riportate maturano al 25% annuale a partire dalla data di concessione originale del 25 lug 2024.

Non sono stati effettuati acquisti o vendite sul mercato aperto; l'attività riguarda esclusivamente la liquidazione delle azioni premio. L'impatto sul flottante e sulla percentuale di proprietà degli insider è trascurabile per gli investitori, ma la comunicazione indica una continua partecipazione al piano di incentivazione a lungo termine dell'azienda.

USNA – Formulario 4 (presentado el 28 de julio de 2025) revela que la Directora Científica Kathryn M. Armstrong ejerció 1,165 unidades restringidas de acciones (RSU) el 25 de julio de 2025 (código M). Cada RSU se convirtió en una acción común.

Para cumplir con las obligaciones fiscales, el emisor retuvo automáticamente 517 acciones a $31.95 por acción (código F). Como resultado, la propiedad directa neta de Armstrong aumentó en 648 acciones, terminando con 648 acciones comunes. La tabla de derivados muestra que tras la transacción quedan 20,256 RSU no adquiridas/restantes. Las RSU reportadas se consolidan al 25% anual desde la fecha original de concesión del 25 de julio de 2024.

No se realizaron compras o ventas en el mercado abierto; la actividad se relaciona únicamente con la liquidación de premios en acciones. El impacto en el flotante y el porcentaje de propiedad de los insiders es insignificante para los inversores, pero la presentación indica una participación continua en el plan de incentivos a largo plazo de la compañía.

USNA – Form 4 (2025년 7월 28일 제출)에 따르면 최고 과학 책임자 Kathryn M. Armstrong가 2025년 7월 25일에 1,165개의 제한 주식 단위(RSU)를 행사했습니다(코드 M). 각 RSU는 보통주 1주로 전환되었습니다.

세금 원천징수 의무를 충족하기 위해 발행사는 자동으로 517주를 주당 $31.95에 원천징수했습니다(코드 F). 그 결과 Armstrong의 순 직접 소유 주식은 648주 증가하여 총 648주가 되었습니다. 파생상품 표에는 거래 후에도 20,256개의 미확정/잔여 RSU가 남아 있는 것으로 나타납니다. 보고된 RSU는 2024년 7월 25일 최초 부여일로부터 연간 25%씩 베스팅됩니다.

공개 시장에서의 매매는 없었으며, 이번 활동은 주식 보상 정산과 관련된 것입니다. 유통 주식 수 및 내부자 소유 비율에 미치는 영향은 투자자에게 미미하지만, 이번 보고는 회사의 장기 인센티브 계획에 지속적으로 참여하고 있음을 시사합니다.

USNA – Formulaire 4 (déposé le 28 juillet 2025) révèle que la Directrice Scientifique Kathryn M. Armstrong a exercé 1 165 unités d’actions restreintes (RSU) le 25 juillet 2025 (code M). Chaque RSU a été convertie en une action ordinaire.

Pour satisfaire aux obligations fiscales, l’émetteur a automatiquement retenu 517 actions au prix de 31,95 $ par action (code F). En conséquence, la propriété directe nette d’Armstrong a augmenté de 648 actions, atteignant un total de 648 actions ordinaires. Le tableau des dérivés montre qu’après la transaction, 20 256 RSU non acquises/restantes sont toujours détenues. Les RSU déclarées acquièrent 25 % par an à partir de la date d’attribution initiale du 25 juillet 2024.

Aucun achat ou vente sur le marché ouvert n’a été effectué ; l’activité concerne uniquement le règlement des attributions d’actions. L’impact sur le flottant et le pourcentage de détention des initiés est négligeable pour les investisseurs, mais le dépôt indique une participation continue au plan d’incitation à long terme de la société.

USNA – Formular 4 (eingereicht am 28. Juli 2025) zeigt, dass die Chief Scientific Officer Kathryn M. Armstrong am 25. Juli 2025 1.165 Restricted Stock Units (RSUs) ausgeübt hat (Code M). Jede RSU wurde in eine Stammaktie umgewandelt.

Zur Erfüllung der Steuerabzugsverpflichtungen behielt der Emittent automatisch 517 Aktien zu je 31,95 $ ein (Code F). Dadurch erhöhte sich Armstrongs Nettobesitz um 648 Aktien auf insgesamt 648 Stammaktien. Die Derivatetabelle zeigt, dass nach der Transaktion noch 20.256 unverfallbare/verbleibende RSUs gehalten werden. Die gemeldeten RSUs werden seit dem ursprünglichen Gewährungsdatum 25. Juli 2024 jährlich zu 25 % vestet.

Es wurden keine Käufe oder Verkäufe am offenen Markt getätigt; die Aktivität betrifft ausschließlich die Abwicklung von Aktienvergütungen. Die Auswirkung auf den Streubesitz und den Insiderbesitz ist für Investoren unerheblich, aber die Meldung signalisiert eine fortgesetzte Teilnahme am langfristigen Anreizprogramm des Unternehmens.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Armstrong Kathryn Michelle

(Last) (First) (Middle)
3838 PARKWAY BLVD.

(Street)
SALT LAKE CITY UT 84120

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF SCIENTIFIC OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/25/2025 M 1,165 A (1) 1,165 D
Common Stock 07/25/2025 F 517 D $31.95 648 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 07/25/2025 M 1,165 (2) (2) Common Stock 1,165 $0 20,256 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. Restricted Stock Units vest 25% on the Anniversary of July 25th, 2024.
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact 07/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many USNA shares did Kathryn Armstrong acquire on 25 Jul 2025?

1,165 shares were issued upon RSU conversion; 648 shares were retained after tax withholding.

What price was used for the tax-withholding share disposal?

Shares were withheld at $31.95 per share (code F).

How many RSUs does the executive still hold after the transaction?

Armstrong continues to hold 20,256 unexercised RSUs.

Does this Form 4 indicate an open-market insider sale?

No. All activity relates to RSU vesting and automatic share withholding; no open-market sale occurred.

When do the reported RSUs vest?

The RSUs vest 25 % each anniversary of 25 Jul 2024.
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

585.51M
10.77M
42.19%
59.03%
4.45%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY